Industrial Pharmacy Section
Age-related medicines under discussion
The use of age-related medicines: Better outcomes for vulnerable patients
Disease comes with age and consequently most medicines are used by the elderly. However, elderly patients have characteristics that differ substantially from younger patients. Understanding older patients and the environments in which they use medicines is, therefore, pivotal for developing suitable medicines. Examples will be given where drug development was unsuccessful and suggestions for improvements will be given. The future of successful medicines therapy in our aging society depends on finding answers to the needs of these vulnerable patients.
The webinar will be delivered by Tom Sam, PhD, FIP Fellow and winner of IPS Medal. Tom has over 30 years of experience in pharmaceutical development and regulatory affairs. He also contributed to the book “Developing drug products in an aging society”.
Founded in 1955, FIP’s Industrial Pharmacy Section (IPS) has expanded to a worldwide industrial pharmacy network. It embraces all functions where industrial pharmacists are employed.
Members of the section benefit from:
- International journal Industrial Pharmacy (quarterly)
- Quarterly IPS Newsletter including early information on pharmaceutical manufacturing science & practice training workshops, up-to-date information on development and manufacturing, biotechnology, QC/QA and the regulation of pharmaceuticals
- Free participation in IPS webinars (typically valued at USD 150 each)
- Reduced rates at FIP symposia and training events
- Global networking opportunities at the annual FIP congress and IPS workshops year-round, providing access to colleagues with technical, quality and regulatory expertise
- Discussion forums on current industrial topics
- Student internships
We invite any pharmacists and scientists working in any area of the pharmaceutical industry or with the regulatory authorities to join us. Enhance and strengthen your professional life and contribute to the international community of industrial pharmacists: click here.
The current Statutes of the Industrial Pharmacy Section were adopted by the FIP Council in 2009.
The executive committee members are as follow:
|President||Michael Anisfeld (United States)|
|Vice President||Sola Solarin (Nigeria)|
|Treasurer||Igor Linhares de Castro (Brazil)|
|Secretary||Ulf Janzon (Sweden)|
Contact us via email@example.com
|Members of IPS ExCo at FIP 2016 Congress in Buenos Aires (Left to right: Anna Laven (Germany), Ulf Janzon (Sweden), Gabrielle Wiederkehr (Switzerland), Kerstin Neumann (Germany), Michael Anisfeld (IPS President, USA), Ching-Yi Hsu (Taiwan), Sini Eskola (Belgium), Mathew Cherian (USA), Didier Mouliom (France), Igor de Castro (Brazil)|
The following roles are also undertaken within ExCo:
|Regulatory||Gabrielle Wiederkehr (Switzerland)|
|WHO Guideline Coordinator||Michael Anisfeld (United States)|
|Regulatory Updates (for IPS Newsletter)||Michael Anisfeld (United States)|
|Media & Communications|
|Newsletter editor||Forum Jalundhwala (India)|
|Industrial Pharmacy editor||Forum Jalundhwala (India)|
|Social media (FB/Linked-In/Twit) editor||Kerstin Neumann (Germany)|
|Website coordinator/Discussion forum manager||Igor de Castro (Brazil)|
|Education & Outreach|
|Awards coordinator||Avanthi Govender (South Africa)|
|Congress coordinator||Ulf Janzon (Sweden)|
|Scientific updates (Congress/Seminars input)||Mathew Cherian (USA)|
|Webinar coordinator||Sola Solarin (Nigeria)|
|IPS development coordinator||Anna Laven|
|Membership management||Didier Mouliom (France)|
|Marketing/Sales coordinator||Anna Laven|